BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25798539)

  • 41. [The evaluation of prognostic value of cyclin B1 expression in patients with resected non-small-cell lung cancer stage I-IIIA--preliminary report].
    Kosacka M; Korzeniewska A; Jankowska R
    Pol Merkur Lekarski; 2010 Feb; 28(164):117-21. PubMed ID: 20369739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: pathologic and prognostic correlations.
    Vargas SO; Leslie KO; Vacek PM; Socinski MA; Weaver DL
    Cancer; 1998 Apr; 82(8):1495-500. PubMed ID: 9554526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.
    Thors B; Halldórsson H; Thorgeirsson G
    Biochim Biophys Acta; 2011 Feb; 1813(2):322-31. PubMed ID: 21145922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMPK is a direct adenylate charge-regulated protein kinase.
    Oakhill JS; Steel R; Chen ZP; Scott JW; Ling N; Tam S; Kemp BE
    Science; 2011 Jun; 332(6036):1433-5. PubMed ID: 21680840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid hormone activates rat liver adenosine 5,-monophosphate-activated protein kinase: relation to CaMKKb, TAK1 and LKB1 expression and energy status.
    Vargas R; Ortega Y; Bozo V; Andrade M; Minuzzi G; Cornejo P; Fernandez V; Videla LA
    J Biol Regul Homeost Agents; 2013; 27(4):989-99. PubMed ID: 24382180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LCAL1 enhances lung cancer survival via inhibiting AMPK-related antitumor functions.
    Li JY; Luo ZQ
    Mol Cell Biochem; 2019 Jul; 457(1-2):11-20. PubMed ID: 30741368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
    Brock SE; Rendon BE; Yaddanapudi K; Mitchell RA
    J Biol Chem; 2012 Nov; 287(45):37917-25. PubMed ID: 22988252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
    Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
    Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
    Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
    J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
    World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2.
    Fang F; Zheng Q; Zhang J; Dong B; Zhu S; Huang X; Wang Y; Zhao B; Li S; Xiong H; Chen J; Wu N; Song SW; Chang C; Yang Y
    Oncol Rep; 2013 Jan; 29(1):297-305. PubMed ID: 23129017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients.
    Chen B; Yang L; Zhang R; Gan Y; Zhang W; Liu D; Chen H; Tang H
    PLoS One; 2017; 12(8):e0182891. PubMed ID: 28792981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells.
    Ishihara S; Yasuda M; Ishizu A; Ishikawa M; Shirato H; Haga H
    Oncotarget; 2015 Mar; 6(7):4602-14. PubMed ID: 25682872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.
    Ocak S; Friedman DB; Chen H; Ausborn JA; Hassanein M; Detry B; Weynand B; Aboubakar F; Pilette C; Sibille Y; Massion PP
    J Thorac Oncol; 2014 Mar; 9(3):324-36. PubMed ID: 24518087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells.
    Mondal A; Roberge J; Gilleran J; Peng Y; Jia D; Akel M; Patel Y; Zoltowski H; Doraiswamy A; Langenfeld J
    Cell Commun Signal; 2022 Jun; 20(1):99. PubMed ID: 35761398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer.
    Harris FT; Rahman SM; Hassanein M; Qian J; Hoeksema MD; Chen H; Eisenberg R; Chaurand P; Caprioli RM; Shiota M; Massion PP
    Cancer Prev Res (Phila); 2014 Jul; 7(7):748-57. PubMed ID: 24819876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions.
    Liu F; Jin R; Liu X; Huang H; Wilkinson SC; Zhong D; Khuri FR; Fu H; Marcus A; He Y; Zhou W
    Oncotarget; 2016 Jan; 7(3):2519-31. PubMed ID: 26506235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation.
    Li Y; Liang R; Sun M; Li Z; Sheng H; Wang J; Xu P; Liu S; Yang W; Lu B; Zhang S; Shan C
    Cancer Lett; 2020 May; 478():82-92. PubMed ID: 32171858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.
    Yang M; Feng Y; Yue C; Xu B; Chen L; Jiang J; Lu B; Zhu Y
    PLoS One; 2018; 13(3):e0193428. PubMed ID: 29499051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.